NCT00206934 is a NA clinical trial of Escitalopram in Healthy Volunteers, sponsored by University of Copenhagen.

Who is sponsoring NCT00206934?

NCT00206934 is sponsored by University of Copenhagen.

What drugs are being tested in NCT00206934?

Interventions in NCT00206934: Escitalopram, escitaolpram.

What condition does NCT00206934 study?

NCT00206934 studies Healthy Volunteers.

Is NCT00206934 still recruiting?

NCT00206934 is currently completed. Last updated 16 September 2011.

Last reviewed 2011-09-16 · How we verify

NCT00206934

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effects of Increased Central Serotonergic Activity on Psychophysiological Parameters of Human Information Processing

Completed NA Last updated 16 September 2011

What this trial tests

NA trial testing Escitalopram in Healthy Volunteers in 40 participants. Completed in 1 March 2006.

Timeline

1 March 2005

Primary endpoint
1 March 2006

1 March 2006

Quick facts

Lead sponsor	University of Copenhagen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	triple
Primary purpose	diagnostic
Enrollment	40
Start date	1 March 2005
Primary completion	1 March 2006
Estimated completion	1 March 2006
Sites	1 location across Denmark

Drugs / interventions tested

Escitalopram (escitalopram) — full drug profile →
escitaolpram — full drug profile →

Conditions studied

Healthy Volunteers — all drugs for Healthy Volunteers →

Sponsor

University of Copenhagen

Who can join

Adults 18 to 35, male only, with Healthy Volunteers. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

The PPI (Prepulse Inhibition of the Startle Response) task
Time frame: Once, 3.5 hrs after intake of capsule
The P50 Suppression task
Time frame: Once, 3.5 hrs after intake of capsule
The P300 ERP task
Time frame: Once, 3.5 hrs after intake of capsule
The mismatch negativity (MMN) task
Time frame: Once, 3.5 hrs after intake of capsule

Sponsor's own description

It is of great clinical relevance to know if selective serotonin re-uptake inhibitors affect information processing. Our hypothesis was that aspects of information processing would be disturbed whereas others would improve.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Escitalopram

Trials testing the same drug.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07331987 — Efficacy and Safety of Probiotics for Anxiety Depression · NA · not yet recruiting
NCT06216535 — Escitalopram in Asthma Patients With Frequent Exacerbation · Phase 2 · recruiting
NCT06937476 — Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole · NA · active not recruiting
NCT05603104 — Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First- · Phase 3 · recruiting

Other recruiting trials for Healthy Volunteers

Currently open trials in the same condition.

NCT07504003 — Influence of Training Session Duration on Improvements in Physiological Resilience to Exercise · NA · recruiting
NCT07446400 — A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuva · Phase 1 · recruiting
NCT07495813 — A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease · Phase 1 · recruiting
NCT07499050 — A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity · Phase 1 · recruiting
NCT07342114 — A Dose-Escalation Study of RO7875913 in Healthy Participants · Phase 1 · recruiting

Other University of Copenhagen trials

Trials by the same sponsor.

NCT07461324 — Surgeons' Prediction of Dental Surgery Complications and the Influence of Patient Characteristics: Development of an AI · not yet recruiting
NCT07389421 — School Meals in Denmark · NA · not yet recruiting
NCT07450690 — Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy · NA · recruiting
NCT07302880 — The Acute Interference of Biotin in Blood Analysis · NA · not yet recruiting
NCT07312981 — The CPH-MBD Cohort Dietary Substudy - Comparison of Methods for Dietary Registrations · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00206934 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Copenhagen
Last refreshed: 16 September 2011

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00206934.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing